作者：
Mardiguian,S. [1]
;
Serres,S. [2]
;
Ladds,E. [3]
;
Campbell,S.J. [4]
;
Wilainam,P. [5]
;
McFadyen,C. [6]
;
McAteer,M. [7]
;
Choudhury,R.P. ;
Smith,P. ;
Saunders,F. ;
Watt,G. ;
Sibson,N.R. ;
Anthony,D.C.
作者单位：
Clinical Medical School, Magdalen College, University of Oxford, Oxford, United Kingdom
[1]
Department of Pharmacology, UCB Pharma S.A., Great Abingdon, United Kingdom
[2]
Department of Antibody Biology, UCB Pharma S.A., Slough, United Kingdom
[3]
CR-UK/MRC Gray Institute for Radiation Oncology and Biology, University of Oxford, Oxford, United
[4]
Department of Pharmacology, University of Oxford, Oxford OX1 3QT, United Kingdom
[5]
Department of Cardiovascular Medicine, University of Oxford, Oxford, United Kingdom
[6]
Department of Pharmacology, UCB Pharma S.A., Slough, United Kingdom
[7]
发布时间
2013-11-20
换一批
